Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals Holding

TNXP· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -52.6% in FY2025

Seth Lederman is the CEO of Tonix Pharmaceuticals Holding and was paid $3.2M in FY2025 (Dec), up 75%.

Pay$100 in the stock at the end of FY22 → $0
CEO pay is from each Tonix Pharmaceuticals Holding proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Seth LedermanFY2025
  2. 2Jessica MorrisFY2025
  3. 3Gregory SullivanFY2025
  4. 4Bradley SaengerFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Tonix Pharmaceuticals Holding paid its 4 named executives $6.8M in total in FY2025 (Dec). CEO Seth Lederman was paid $3.2M of that.

Name
Seth LedermanChief Executive Officer
Jessica MorrisChief Operations Officer
Gregory SullivanChief Medical Officer
Bradley SaengerChief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Tonix Pharmaceuticals Holding. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AMar 30, 2026FY2025
Annual report10-KMar 12, 2026FY2025
Proxy statementDEF 14AMar 31, 2025FY2024
Annual report10-KMar 18, 2025FY2024
Annual report10-KApr 1, 2024FY2023
Proxy statementDEF 14ADec 26, 2023—
For the press:Download CSVDownload PNGHow to use our data